EIG
NVLN
EdgePoint Investment Group’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,674,185
| Closed | -$2.57M | – | 43 |
|
|
2019
Q4 | $2.57M | Buy |
3,674,185
+573,254
| +18% | +$401K | 0.02% | 36 |
|
|
2019
Q3 | $2.25M | Buy |
3,100,931
+269,376
| +10% | +$195K | 0.02% | 36 |
|
|
2019
Q2 | $2.21M | Buy |
2,831,555
+410,296
| +17% | +$320K | 0.02% | 36 |
|
|
2019
Q1 | $2.98M | Buy |
2,421,259
+52,440
| +2% | +$64.5K | 0.03% | 38 |
|
|
2018
Q4 | $1.99M | Buy |
2,368,819
+173,756
| +8% | +$146K | 0.02% | 39 |
|
|
2018
Q3 | $6.5M | Hold |
2,195,063
| – | – | 0.07% | 41 |
|
|
2018
Q2 | $8.08M | Hold |
2,195,063
| – | – | 0.1% | 39 |
|
|
2018
Q1 | $7.68M | Buy |
2,195,063
+3,150
| +0.1% | +$11K | 0.11% | 39 |
|
|
2017
Q4 | $6.84M | Buy |
2,191,913
+1,153,347
| +111% | +$3.6M | 0.1% | 39 |
|
|
2017
Q3 | $7.3M | Buy |
+1,038,566
| New | +$7.3M | 0.11% | 41 |
|